Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2020	Jun. 30, 2019
Current assets:
Cash	$ 356,619	$ 41,335
Prepaid expenses	3,983	8,005
Deposits and other receivables	1,000	1,000
Total current assets	361,602	50,340
Property and equipment, net (Note 3)	1,575	2,616
Total assets	363,177	52,956
Current liabilities:
Accounts payable and accrued expenses	719,919	715,554
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $37,500 and $36,000, respectively (Note 8)	34,900	33,400
Deferred compensation (Note 5)	652,367	874,162
Loan payable and accrued interest (Note 6)	9,506,298	9,303,270
Total current liabilities	10,913,484	10,926,386
Convertible notes payable - affiliates (Note 7)	4,559,520	3,801,168
Total liabilities	15,473,004	14,727,554
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 30,559,005 and 28,068,688 shares issued, respectively; 29,854,696 and 27,364,379 shares outstanding, respectively
Additional paid-in capital	111,405,399	110,126,802
Subscription receivable - affiliates (Note 9)	(504,650)	(504,650)
Accumulated deficit	(126,058,195)	(124,346,158)
Total Bion’s stockholder deficit	(15,157,446)	(14,724,006)
Noncontrolling interest	47,619	49,408
Total deficit	(15,109,827)	(14,674,598)
Total liabilities and deficit	363,177	52,956
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock